Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Glioma × Angptl4 protein, mouse × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Fasting 8 Breast Neoplasms 3 Prostatic Neoplasms 2 Intermittent Fasting 2 Colorectal Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumors 1 Sarcoma 1 Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Neoplasms 1 Lymphoma 1 Liposarcoma 1 Infertility 1 Histiocytoma, Malignant Fibrous 1 Glioma 1 Fibrosis 1 Fasting in Malignant Solid Tumors 1 Esophageal Neoplasms 1 Dermatofibrosarcoma 1 Childhood Cancer Survivors 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Temozolomide 134 Bevacizumab 62 Radiotherapy 53 Magnetic Resonance Spectroscopy 52 Irinotecan 26 Carboplatin 22 Surgical Procedures, Operative 18 Radiation 18 Carmustine 18 Specimen Handling 17 Nivolumab 15 Lomustine 15 Biopsy 15 Aminolevulinic Acid 15 pembrolizumab 12 Radiotherapy, Intensity-Modulated 12 trametinib 11 Radiosurgery 11 Cyclophosphamide 11 fluorodopa F 18 9 Topotecan 9 IL13-PE38 9 Everolimus 9 Erlotinib Hydrochloride 9 ribociclib 8 dabrafenib 8 X-Rays 8 Imatinib Mesylate 8 Filgrastim 8 Etoposide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04461938 2024-10-17

ERGO3

Goethe University

Phase NA Active not recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡